However, there is some controversy: one work demonstrated that miRNA-205 expression is higher in ER+/PR+/HER2+ BC than in any other BC subtypes, while another revealed a high level of miRNA-205 expression in ER−/PR−/HER2- tumors [21]. Here, ERBB2 is linked to breast cancer.